Development and validation of the Wisconsin Smoking Withdrawal Scale.

New methods for tobacco dependence treatment research. Ann Behav Med (2011) 2.44

Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal. JAMA Psychiatry (2013) 2.11

A vaccine against nicotine for smoking cessation: a randomized controlled trial. PLoS One (2008) 2.07

Low-level smoking among Spanish-speaking Latino smokers: relationships with demographics, tobacco dependence, withdrawal, and cessation. Nicotine Tob Res (2009) 1.96

Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Exp Clin Psychopharmacol (2007) 1.94

The early time course of smoking withdrawal effects. Psychopharmacology (Berl) (2006) 1.90

Refining the tobacco dependence phenotype using the Wisconsin Inventory of Smoking Dependence Motives. J Abnorm Psychol (2008) 1.86

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J Psychopharmacol (2014) 1.82

Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl) (2004) 1.75

Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol (2010) 1.60

Tobacco withdrawal components and their relations with cessation success. Psychopharmacology (Berl) (2011) 1.60

Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction (2008) 1.53

Life 1 year after a quit attempt: real-time reports of quitters and continuing smokers. Ann Behav Med (2012) 1.52

An experimental investigation of reactivity to ecological momentary assessment frequency among adults trying to quit smoking. Addiction (2015) 1.49

Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA (2014) 1.44

Damage to the insula leads to decreased nicotine withdrawal during abstinence. Addiction (2015) 1.44

Nicotine withdrawal increases threat-induced anxiety but not fear: neuroadaptation in human addiction. Biol Psychiatry (2010) 1.41

Associations of mindfulness with nicotine dependence, withdrawal, and agency. Subst Abus (2009) 1.35

Efficacy of bupropion alone and in combination with nicotine gum. Nicotine Tob Res (2007) 1.33

Why two smoking cessation agents work better than one: role of craving suppression. J Consult Clin Psychol (2011) 1.33

A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome. Addict Behav (2010) 1.32

The Wisconsin Predicting Patients' Relapse questionnaire. Nicotine Tob Res (2009) 1.20

Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology (Berl) (2005) 1.20

Time-varying processes involved in smoking lapse in a randomized trial of smoking cessation therapies. Nicotine Tob Res (2014) 1.19

Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav (2007) 1.17

An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation. Psychophysiology (2009) 1.15

Is the ten-item Questionnaire of Smoking Urges (QSU-brief) more sensitive to abstinence than shorter craving measures? Psychopharmacology (Berl) (2009) 1.14

Associations between Cloninger's temperament dimensions and acute tobacco withdrawal. Addict Behav (2007) 1.13

Advancing the understanding of craving during smoking cessation attempts: a demonstration of the time-varying effect model. Nicotine Tob Res (2013) 1.12

Early cessation success or failure among women attempting to quit smoking: trajectories and volatility of urge and negative mood during the first postcessation week. J Abnorm Psychol (2011) 1.11

Higher nicotine levels in schizophrenia compared with controls after smoking a single cigarette. Nicotine Tob Res (2010) 1.09

Contextual and subjective antecedents of smoking in a college student sample. Nicotine Tob Res (2010) 1.04

Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology (2013) 1.02

A multimodal approach to assessing the impact of nicotine dependence, nicotine abstinence, and craving on negative affect in smokers. Exp Clin Psychopharmacol (2011) 1.01

Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures. Addiction (2009) 1.01

Nicotine and food deprivation decrease the ability to resist smoking. Psychopharmacology (Berl) (2010) 1.01

Are tobacco dependence and withdrawal related amongst heavy smokers? Relevance to conceptualizations of dependence. J Abnorm Psychol (2012) 1.00

Understanding the role of cessation fatigue in the smoking cessation process. Drug Alcohol Depend (2013) 1.00

Gender differences in affective response to acute nicotine administration and deprivation. Addict Behav (2006) 1.00

Subliminal processing of smoking-related and affective stimuli in tobacco addiction. Exp Clin Psychopharmacol (2008) 0.98

A dynamical systems approach to understanding self-regulation in smoking cessation behavior change. Nicotine Tob Res (2013) 0.97

Light versus heavy smoking among African American men and women. Addict Behav (2008) 0.97

Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial. J Dual Diagn (2012) 0.97

Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology (Berl) (2014) 0.95

The Smoking Consequences Questionnaire: Factor structure and predictive validity among Spanish-speaking Latino smokers in the United States. Nicotine Tob Res (2009) 0.93

An Ecological Momentary Assessment analysis of relations among coping, affect and smoking during a quit attempt. Addiction (2010) 0.93

Five population-based interventions for smoking cessation: a MOST trial. Transl Behav Med (2014) 0.92

Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures. Psychol Assess (2009) 0.92

A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION. BMC Public Health (2012) 0.92

Prequit fMRI responses to pleasant cues and cigarette-related cues predict smoking cessation outcome. Nicotine Tob Res (2013) 0.92

Nicotine deprivation influences P300 markers of cognitive control. Neuropsychopharmacology (2013) 0.91

Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin (2014) 0.90

Abstinence-related expectancies predict smoking withdrawal effects: implications for possible causal mechanisms. Psychopharmacology (Berl) (2013) 0.89

An ecological momentary assessment analysis of prequit markers for smoking-cessation failure. Exp Clin Psychopharmacol (2012) 0.89

Anhedonia as a component of the tobacco withdrawal syndrome. J Abnorm Psychol (2014) 0.89

Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence? Addict Behav (2009) 0.89

Pathways linking socioeconomic status and postpartum smoking relapse. Ann Behav Med (2013) 0.89

Functional data analysis for dynamical system identification of behavioral processes. Psychol Methods (2013) 0.88

Comparative dynamics of four smoking withdrawal symptom scales. Addiction (2012) 0.88

A cross-lagged path analysis of five intrapersonal determinants of smoking cessation. Drug Alcohol Depend (2014) 0.85

Affective trajectories before and after a quit attempt among smokers with current depressive disorders. Nicotine Tob Res (2013) 0.84

Cortisol levels decrease after acute tobacco abstinence in regular smokers. Hum Psychopharmacol (2014) 0.84

Paths to tobacco abstinence: A repeated-measures latent class analysis. J Consult Clin Psychol (2015) 0.83

Sensory modality of smoking cues modulates neural cue reactivity. Psychopharmacology (Berl) (2012) 0.83

Effects of 24 hours of tobacco withdrawal and subsequent tobacco smoking among low and high sensation seekers. Nicotine Tob Res (2011) 0.82

Withdrawal: Expanding a Key Addiction Construct. Nicotine Tob Res (2015) 0.82

Subjective sleep disturbance during a smoking cessation program: associations with relapse. Addict Behav (2011) 0.81

Negative reinforcement smoking outcome expectancies are associated with affective response to acute nicotine administration and abstinence. Drug Alcohol Depend (2011) 0.81

Structural and predictive equivalency of the Wisconsin Smoking Withdrawal Scale across three racial/ethnic groups. Nicotine Tob Res (2011) 0.80

Affective reactivity during smoking cessation of never-quitters as compared with that of abstainers, relapsers, and continuing smokers. Exp Clin Psychopharmacol (2011) 0.80

Associations of attention-deficit hyperactivity disorder symptom dimensions with smoking deprivation effects in adult smokers. Psychol Addict Behav (2014) 0.80

Efficacy of mindfulness-based addiction treatment (MBAT) for smoking cessation and lapse recovery: A randomized clinical trial. J Consult Clin Psychol (2016) 0.79

Relations among affect, abstinence motivation and confidence, and daily smoking lapse risk. Psychol Addict Behav (2014) 0.79

Attention bias in nicotine withdrawal and under stress. Psychol Addict Behav (2009) 0.79

Tobacco withdrawal symptoms mediate motivation to reinstate smoking during abstinence. J Abnorm Psychol (2015) 0.79

The effects of acute abstinence from smoking and performance-based rewards on performance monitoring. Psychopharmacology (Berl) (2013) 0.79

Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit. Drug Alcohol Depend (2015) 0.78

Nicotine levels, withdrawal symptoms, and smoking reduction success in real world use: A comparison of cigarette smokers and dual users of both cigarettes and E-cigarettes. Drug Alcohol Depend (2016) 0.78

Measurement of nicotine withdrawal symptoms: linguistic validation of the Wisconsin Smoking Withdrawal Scale (WSWS) in Malay. BMC Med Res Methodol (2010) 0.78

The effects of nicotine dose expectancy and motivationally relevant distracters on vigilance. Psychol Addict Behav (2014) 0.78

Dispositional Mindfulness Predicts Enhanced Smoking Cessation and Smoking Lapse Recovery. Ann Behav Med (2016) 0.78

Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology (Berl) (2014) 0.78

Clinical significance of early smoking withdrawal effects and their relationships with nicotine metabolism: preliminary results from a pilot study. Nicotine Tob Res (2013) 0.78

Abstinence rates among college cigarette smokers enrolled in a randomized clinical trial evaluating Quit and Win contests: The impact of concurrent hookah use. Prev Med (2015) 0.77

Bupropion-SR for smoking cessation in early recovery from alcohol dependence: a placebo-controlled, double-blind pilot study. Am J Drug Alcohol Abuse (2011) 0.77

Anticipation of smoking sufficiently dampens stress reactivity in nicotine-deprived smokers. J Abnorm Psychol (2015) 0.77

A randomized clinical trial of a tailored behavioral smoking cessation preparation program. Behav Res Ther (2015) 0.77

Cognitive conflict following appetitive versus negative cues and smoking cessation failure. Psychopharmacology (Berl) (2011) 0.77

Distress Tolerance as a Correlate of Tobacco Dependence and Motivation: Incremental Relations over and above Anxiety and Depressive Symptoms. Behav Med (2015) 0.77

Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers. Pharmacol Biochem Behav (2015) 0.77

A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females. J Clin Psychopharmacol (2011) 0.77

Associations of functional and dysfunctional impulsivity to smoking characteristics. J Addict Med (2012) 0.76

Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers. Nicotine Tob Res (2014) 0.76

CHRNA5 variants moderate the effect of nicotine deprivation on a neural index of cognitive control. Genes Brain Behav (2014) 0.76

Cigarette craving is associated with blunted reward processing in nicotine-dependent smokers. Drug Alcohol Depend (2015) 0.76

Feasibility and patient satisfaction with smoking cessation interventions for prevention of healthcare-associated infections in inpatients. Subst Abuse Treat Prev Policy (2016) 0.75

Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence. Psychopharmacology (Berl) (2016) 0.75

Prospective Evaluation of Factors Predicting Nicotine Withdrawal Symptoms Among Korean Americans. J Smok Cessat (2015) 0.75

What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt. Addiction (2016) 0.75

Multilevel factor analysis of smokers' real-time negative affect ratings while quitting. Psychol Assess (2016) 0.75

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62

Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res (1989) 7.78

The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA (1994) 6.02

Trends in cigarette smoking in the United States. Educational differences are increasing. JAMA (1989) 5.59

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA (1997) 5.47

Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA (1989) 4.90

Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA (1994) 3.83

Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA (1992) 3.77

The reliability of self-reported cigarette consumption in the United States. Am J Public Health (1989) 3.35

Gender differences in smoking cessation. J Consult Clin Psychol (1999) 2.84

Varying nicotine patch dose and type of smoking cessation counseling. JAMA (1995) 2.82

Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79

The motivation to use drugs: a psychobiological analysis of urges. Nebr Symp Motiv (1986) 2.56

Cigarette smoking prevalence by occupation in the United States. A comparison between 1978 to 1980 and 1987 to 1990. J Occup Med (1994) 2.52

US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care (2000) 2.44

Quitting smoking in the United States in 1986. J Natl Cancer Inst (1990) 2.42

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33

Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clin Proc (1995) 2.32

Postcessation cigarette use: the process of relapse. Addict Behav (1990) 2.21

Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11

Hairpins are formed by the single DNA strands of the fragile X triplet repeats: structure and biological implications. Proc Natl Acad Sci U S A (1995) 2.10

Smoking outcome expectancies: factor structure, predictive validity, and discriminant validity. J Abnorm Psychol (1994) 2.06

Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol (1998) 1.84

RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferase. Nucleic Acids Res (1988) 1.71

Race/ethnicity and the 2000 census: implications for public health. Am J Public Health (2000) 1.61

Smoking cessation treatment and the good doctor club. Am J Public Health (1995) 1.60

CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57

CFTR: mechanism of anion conduction. Physiol Rev (1999) 1.55

Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med (1999) 1.54

Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol (1999) 1.47

The effects of athletic massage on delayed onset muscle soreness, creatine kinase, and neutrophil count: a preliminary report. J Orthop Sports Phys Ther (1994) 1.40

Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res (2001) 1.36

Trends in smoking by age and sex, United States, 1974-1987: the implications for disease impact. Prev Med (1990) 1.35

Scheduled reduced smoking: effects on smoking abstinence and potential mechanisms of action. Addict Behav (1998) 1.32

DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis (1995) 1.31

Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med (1998) 1.31

Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J (1998) 1.30

Relation between self-reported affect and drug urges and cravings in continuing and withdrawing smokers. J Abnorm Psychol (1992) 1.29

Evaluating the construct validity of psychopathy in black and white male inmates: three preliminary studies. J Abnorm Psychol (1990) 1.24

Using brain MERMER testing to detect knowledge despite efforts to conceal. J Forensic Sci (2001) 1.22

Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22

Gender and racial/ethnic differences in tobacco-dependence treatment: a commentary and research recommendations. Nicotine Tob Res (2001) 1.20

Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol (1992) 1.19

Any further progress in smoking cessation treatment? Nicotine Tob Res (2001) 1.18

Manipulating smoking motivation: impact on an electrophysiological index of approach motivation. J Abnorm Psychol (1999) 1.17

Assessing the generalizability of smoking studies. Addiction (1997) 1.17

Approach and avoidance motivation in psychopathic criminal offenders during passive avoidance. J Pers Soc Psychol (1997) 1.17

Purification of human DNA (cytosine-5-)-methyltransferase. J Cell Biochem (1985) 1.16

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Prev Med (2000) 1.14

Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest (1994) 1.13

Size of the directing moiety at carbon 5 of cytosine and the activity of human DNA(cytosine-5) methyltransferase. Biochem Biophys Res Commun (1987) 1.12

Quantification of lumbar function. Part 2: Sagittal plane trunk strength in chronic low-back pain patients. Spine (Phila Pa 1976) (1985) 1.10

Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats. J Pharmacol Exp Ther (2003) 1.09

Smokeless tobacco use in the United States: the adult use of tobacco surveys. NCI Monogr (1989) 1.09

Transitions out of high school: time of increased cancer risk? Prev Med (1997) 1.08

Carcinoma of the breast. A clinical study. Arch Surg (1978) 1.05

Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology (Berl) (1996) 1.04

The epidemiology of tobacco use, dependence, and cessation in the United States. Prim Care (1999) 1.04

Progesterone withdrawal I: pro-convulsant effects. Brain Res (1998) 1.03

Initial ATP Formation, NADP Reduction, CO(2) Fixation, and Chloroplast Flattening Upon Illuminating Pea Leaves. Plant Physiol (1969) 1.01

Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal. Eur J Neurosci (2003) 0.98

The influence of agarose--DNA affinity on the electrophoretic separation of DNA fragments in agarose gels. Anal Biochem (1983) 0.98

Tobacco withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol (1995) 0.98

Reversal of somatostatin inhibition of insulin and glucagon secretion. Diabetes (1976) 0.97

Under-use of tobacco dependence treatment among Wisconsin's fee-for-service Medicaid recipients. WMJ (2001) 0.96

Progesterone withdrawal. II: insensitivity to the sedative effects of a benzodiazepine. Brain Res (1998) 0.96

Quadruplex DNA formation in a region of the tRNA gene supF associated with hydrogen peroxide mediated mutations. Biochemistry (1991) 0.95